Abstract
Adherence is defined as 'the extent to which a patient's behavior corresponds with recommendations from a health care provider'. In all chronic diseases, including asthma, patient nonadherence to medical recommendations is common. In asthma, low rates of adherence to preventive medication are associated with higher rates of hospitalization and death. Many patients choose not to take their medication because they perceive it to be unnecessary or because they are concerned about potential adverse effects. Approximately one third of asthma patients have strong concerns about adverse effects from inhaled corticosteroids (ICSs). Clinicians must be prepared to work in an ongoing partnership with patients to ensure that they are offered a clear rationale as to why ICS are necessary and to address their concerns about potential adverse effects. This approach, based on a detailed examination of patients' perspectives on asthma and its treatment, and an open, nonjudgmental manner on the part of the clinician, is consistent with the idea of concordance. Both the efficacy of a medication and patient adherence to the therapeutic regimen influence the effectiveness of a treatment. This article will review the underlying reasons for patient nonadherence and describe the role played by clinicians in promoting optimal medicine management.
References
1. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975; 13:10–24.
2. Haynes RB, Taylor DW, Sackett DL. Compliance in healthcare. Baltimore: Johns Hopkins University Press;1979.
3. The Global Initiative for Asthma. GINA Report, Global Strategy for Asthma Management and Prevention. Updated Dec. 2011 [Internet]. cited 2012 Oct 31. The Global Initiative For Asthma;c2011. Available from: http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html.
4. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002; 17:17–32.
5. Foster J, Aucott L, van der Werf R, van der Meijden MJ, van der Molen GS. Many patients perceive numerous side effects of inhaled corticosteroids. Primary Care Respir. 2003; 12:68–69.
7. Sabate E. Adherence to long-term therapies: evidence for action, non-communicable disease and health adherence to long term therapies project. Geneva, Switzerland: World Health Organization;2003.
8. Horne R. Concordance and medicines management in the respiratory arena. London, UK: Hayward Medical Publications;2003.
9. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997; 79:177–185.
10. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996; 98(6 Pt 1):1051–1057.
11. Kim C, Feldman HI, Joffe M, Tenhave T, Boston R, Apter AJ. Influences of earlier adherence and symptoms on current symptoms: a marginal structural models analysis. J Allergy Clin Immunol. 2005; 115:810–814.
12. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004; 170:1281–1285.
13. Onyirimba F, Apter A, Reisine S, Litt M, McCusker C, Connors M, et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol. 2003; 90:411–415.
14. Bender BG. Screening patients for nonadherence. Female Patient. 2005; 30:1–4.
15. Diette GB, Wu AW, Skinner EA, Markson L, Clark RD, McDonald RC, et al. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. Arch Intern Med. 1999; 159:2697–2704.
16. Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy. 1991; 66:294–299.
17. Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992; 146:1559–1564.
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:67–74.
20. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42:200–209.
21. Weinman J. Providing written information for patients: psychological considerations. J R Soc Med. 1990; 83:303–305.
22. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004; 42:102–109.
23. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47:555–567.
24. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004; 15:38–44.
25. Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005; 3:23–30.
26. Main J, Weinman J, Horne R. Explaining adherence to preventer medication in asthma. Int J Behav Med. 2004; 11:Suppl. 72.
27. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005; (4):CD000011.
28. Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990; 150:1664–1668.
29. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001; 21:1464–1467.
30. Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002; 24:302–316.
31. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004; 113:245–251.
32. Venables TL, Addlestone MB, Smithers AJ. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via a disc-inhaler at an equal dose of 400 mcg in adult asthmatics. Br J Clin Res. 1996; 7:15–32.
33. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993; 12:93–102.
34. Roter DL, Hall JA. Strategies for enhancing patient adherence to medical recommendations. JAMA. 1994; 271:80.
35. Wissow LS, Roter D, Bauman LJ, Crain E, Kercsmar C, Weiss K, et al. Patient-provider communication during the emergency department care of children with asthma. The National Cooperative Inner-City Asthma Study, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD. Med Care. 1998; 36:1439–1450.